Abstract
This patent application claims the identification and preparation of novel amidino compounds and the use of these compounds for the treatment of conditions where there is a need to inhibit nitric oxide (NO) synthase (NOS). More specifically, claims are made for use in arthritis, asthma, ileus and migraine.